Detailed answers about ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED, including incorporation, status, business activity, and accounts information.
When was ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED founded?
ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED was officially incorporated on 24 June 2025 and is registered under company number 16539429. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED?
ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED do?
ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED operates in the following sectors: 21100 - Manufacture of basic pharmaceutical products, 46460 - Wholesale of pharmaceutical goods. These SIC codes provide insight into the company's business activities and industry focus.
What is ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED's registered address?
The registered office address of ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED is UNIT G4 RIVERSIDE INDUSTRIAL ESTATE, RIVERSIDE WAY, DARTFORD, KENT, ENGLAND, DA1 5BS. This is the official address filed with Companies House for legal and statutory correspondence.
Is ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED financially stable?
Financial accounts for ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.